Search Results - "nanoparticle"

Drug targeting by magnetically responsive colloids by Arias, José L.

Subjects: An electronic book accessible through the World Wide Web; click to view

Nanotechnology for intracellular nucleic acid delivery

Table of Contents: “…Contents: Using nucleic acids as therapeutics -- Nucleic acid delivery systems -- Nucleosome mimicking polymer particles -- Cationic shell-crosslinked knedel-like nanoparticles (cSCKs) -- High density spherical nucleic acids (SNAs) -- Hollow SNAs.…”
Get full text
Series

Increasing tumor targeting efficacy by nanomedicine

Table of Contents: “…Contents: Rationale: low target efficacy drugs -- Physiochemical properties of nanoparticles -- Mesenchymal stem cell-nanodrug delivery -- Transportation to cancer organelles.…”
Get full text
Series

Nanotechnology for intracellular nucleic acid delivery

Table of Contents: “…Contents: Using nucleic acids as therapeutics -- Nucleic acid delivery systems -- Nucleosome mimicking polymer particles -- Cationic shell-crosslinked knedel-like nanoparticles (cSCKs) -- High density spherical nucleic acids (SNAs) -- Hollow SNAs.…”
Get full text
Series

Nanotechnology for intracellular nucleic acid delivery

Table of Contents: “…Contents: Using nucleic acids as therapeutics -- Nucleic acid delivery systems -- Nucleosome mimicking polymer particles -- Cationic shell-crosslinked knedel-like nanoparticles (cSCKs) -- High density spherical nucleic acids (SNAs) -- Hollow SNAs.…”
Get full text
Series

Increasing tumor targeting efficacy by nanomedicine

Table of Contents: “…Contents: Rationale: low target efficacy drugs -- Physiochemical properties of nanoparticles -- Mesenchymal stem cell-nanodrug delivery -- Transportation to cancer organelles.…”
Get full text
Series

Increasing tumor targeting efficacy by nanomedicine

Table of Contents: “…Contents: Rationale: low target efficacy drugs -- Physiochemical properties of nanoparticles -- Mesenchymal stem cell-nanodrug delivery -- Transportation to cancer organelles.…”
Get full text
Series

Polysaccharide based Nano-Biocarrier in Drug Delivery /

Table of Contents: “…Chapter 2 --Oral Absorption of Polysaccharide Nanoparticles Loaded with --…”
Click here to view.

Hybrid nanostructures in cancer therapy

Table of Contents: “….] -- Functionalized carbon nanotubes : new tools in nanomedicine / Mohsen Adeli and Masoumeh Bavadi -- Quantum dot-polymer hybrid nanomaterials in nanomedicine / Mohsen Adeli, Masoumeh Parsamanesh, and Elham Sadeghi -- Gold nanoparticle-polymer hybrid nanomaterials and biological applications / Mohsen Adeli, Fahimeh Madani, and Raziyeh Yadollahi -- Application of TiO2 nanomaterials for photocatalytic destruction of biological species and cancer therapy / Alireza Khataee and Mehrangiz Fathinia.…”
An electronic book accessible through the World Wide Web; click to view

Natural products chemistry : biomedical and pharmaceutical phytochemistry /

Table of Contents: “…Bryophytes : Natural Biomonitors / Rajeev Singh, Hema Joshi, and Anamika Singh -- Applied Techniques for Extraction, Purification, and Characterization of Medicinal Plants Active Compounds / Crystel Aleyvick Sierra Rivera, Luis Enrique Cobos Puc, Maria Del Carmen Rodríguez Salazar, Anna Iliná, Elda Patricia Segura Ceniceros, Laura María Solís Salas, Sonia Yesenia Silva Belmares -- Panoramic View on Biological Barricades and Its Influence on Polysaccharide Nanoparticle Transport : An Updated Status in Cancer / Maya Sreeranganathan, Babukuttan Sheela Unnikrishnan, Preethi Gopalakrishnan Usha, and Therakathinal Thankappan Sreelekha -- Selective Targeting of Human Colon Cancer HCT116 Cells by Phytomediated Silver Nanoparticles / V.S. …”
Taylor & Francis
OCLC metadata license agreement

Systemic RNA interference (RNAi) therapeutics for the treatment of HIV-1

Table of Contents: “…-- Major goals of anti-HIV therapies -- Combinatorial RNA based therapy for HIV -- Applying RNAi for the treatment of human diseases -- treat HIV infection by systemic delivery of small RNAs -- Aptamers -- Chimeric-siRNA aptamer uptake into gp120 expressing cells -- Aptamer-targeted RNA interference for HIV-1 therapy -- Aptamer and aptamer chimera mediated inhibition of HIV-1 -- Small animal model for studying anti-HIV RNAi based therapies -- Both aptamer and aptamer chimera inhibit HIV infection -Aptamer and chimeric aptamer-siRNA prevent CD4+ cell decline -- Aptamer and dsiRNAS effect on viral load -- Flexible PAMAM dendrimers with a triethanolamine core -- Dendrimers plus siRNAs form nanoparticles, protect siRNA from degradation and deliver siRNAs to T-lymphocytes -- G5 dendrimer delivered siRNAs down regulate target mRNAs in vitro -- Multiplex siRNAs for HIV-1 treatment -- In vivo analyses of G5 dendrimer delivered siRNAs -- Reductions in HIV loads following dendrimer siRNA injections -- Dendrimer-siRNA complexes protect HIV infected RAG-hu mice from CD4 T cell loss -- Bio distribution of G5 dendrimer siRNAs.…”
Get full text
Series

Systemic RNA interference (RNAi) therapeutics for the treatment of HIV-1

Table of Contents: “…-- Major goals of anti-HIV therapies -- Combinatorial RNA based therapy for HIV -- Applying RNAi for the treatment of human diseases -- treat HIV infection by systemic delivery of small RNAs -- Aptamers -- Chimeric-siRNA aptamer uptake into gp120 expressing cells -- Aptamer-targeted RNA interference for HIV-1 therapy -- Aptamer and aptamer chimera mediated inhibition of HIV-1 -- Small animal model for studying anti-HIV RNAi based therapies -- Both aptamer and aptamer chimera inhibit HIV infection -Aptamer and chimeric aptamer-siRNA prevent CD4+ cell decline -- Aptamer and dsiRNAS effect on viral load -- Flexible PAMAM dendrimers with a triethanolamine core -- Dendrimers plus siRNAs form nanoparticles, protect siRNA from degradation and deliver siRNAs to T-lymphocytes -- G5 dendrimer delivered siRNAs down regulate target mRNAs in vitro -- Multiplex siRNAs for HIV-1 treatment -- In vivo analyses of G5 dendrimer delivered siRNAs -- Reductions in HIV loads following dendrimer siRNA injections -- Dendrimer-siRNA complexes protect HIV infected RAG-hu mice from CD4 T cell loss -- Bio distribution of G5 dendrimer siRNAs.…”
Get full text
Series

Systemic RNA interference (RNAi) therapeutics for the treatment of HIV-1

Table of Contents: “…-- Major goals of anti-HIV therapies -- Combinatorial RNA based therapy for HIV -- Applying RNAi for the treatment of human diseases -- treat HIV infection by systemic delivery of small RNAs -- Aptamers -- Chimeric-siRNA aptamer uptake into gp120 expressing cells -- Aptamer-targeted RNA interference for HIV-1 therapy -- Aptamer and aptamer chimera mediated inhibition of HIV-1 -- Small animal model for studying anti-HIV RNAi based therapies -- Both aptamer and aptamer chimera inhibit HIV infection -Aptamer and chimeric aptamer-siRNA prevent CD4+ cell decline -- Aptamer and dsiRNAS effect on viral load -- Flexible PAMAM dendrimers with a triethanolamine core -- Dendrimers plus siRNAs form nanoparticles, protect siRNA from degradation and deliver siRNAs to T-lymphocytes -- G5 dendrimer delivered siRNAs down regulate target mRNAs in vitro -- Multiplex siRNAs for HIV-1 treatment -- In vivo analyses of G5 dendrimer delivered siRNAs -- Reductions in HIV loads following dendrimer siRNA injections -- Dendrimer-siRNA complexes protect HIV infected RAG-hu mice from CD4 T cell loss -- Bio distribution of G5 dendrimer siRNAs.…”
Get full text
Series